Floatz logo

Abemaciclib

FANCA Gene Mutation

University of California, DavisSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the FANCA Gene Mutation cohort.

Asset / SponsorPhaseRating
Abiraterone Acetate
Qian Qin
Phase 2CCC
PREDNISONE TABLETS
Qian Qin
Phase 2CCC
Docetaxel
Qian Qin
Phase 2CCC
Niraparib
Qian Qin
Phase 2CCC

Same molecule, other indications

Abemaciclib is also rated in:

hormone receptor-positive breast cancerDormant
BBB
Indicative ·
72 / 100
View asset →
estrogen-receptor positive breast cancerDormant
BB
Indicative ·
70 / 100
View asset →
Hormone Receptor Positive TumorDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →